Evidence map›Paper›PMID 26285804›Full record

ArticleBioscience reports2015

Effect of BIX-01294 on H3K9me2 levels and the imprinted gene Snrpn in mouse embryonic fibroblast cells.

Peng Chen, Jian-Feng Yao, Rong-Fu Huang, Fang-Fang Zheng, Xiao-Hong Jiang, Xuan Chen, Juan Chen, Ming Li, Hong-Feng Huang, Yi-Ping Jiang and 2 more

Abstract read
In one paragraph

Article in Bioscience reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Targeting Epigenetics in Cancer.Annual review of pharmacology and toxicology · 2018
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Peng ChenThe First Affiliated Hospital, Fujian Medical University, Fuzhou, PR China.
Jian-Feng YaoCollege of Preclinical Medicine, Fujian Medical University, Fuzhou, PR China.
Rong-Fu HuangThe Second Affiliated Hospital, Fujian Medical University, Quanzhou, PR China.
Fang-Fang ZhengQuanzhou Medical College, Quanzhou, PR China Institutes of Reproductive Sciences, Fujian Medical University, Fuzhou, PR China.
Xiao-Hong JiangCollege of Preclinical Medicine, Fujian Medical University, Fuzhou, PR China Institutes of Reproductive Sciences, Fujian Medical University, Fuzhou, PR China.
Xuan ChenCollege of Preclinical Medicine, Fujian Medical University, Fuzhou, PR China Institutes of Reproductive Sciences, Fujian Medical University, Fuzhou, PR China.
Juan ChenCollege of Preclinical Medicine, Fujian Medical University, Fuzhou, PR China Institutes of Reproductive Sciences, Fujian Medical University, Fuzhou, PR China.
Ming LiCollege of Preclinical Medicine, Fujian Medical University, Fuzhou, PR China Institutes of Reproductive Sciences, Fujian Medical University, Fuzhou, PR China.
Hong-Feng HuangCollege of Preclinical Medicine, Fujian Medical University, Fuzhou, PR China Institutes of Reproductive Sciences, Fujian Medical University, Fuzhou, PR China.
Yi-Ping JiangInstitutes of Reproductive Sciences, Fujian Medical University, Fuzhou, PR China.
Yan-Fang HuangThe First Affiliated Hospital, Fujian Medical University, Fuzhou, PR China hyffjlyxl@163.com yangxiaoyu683@163.com.
Xiao-Yu YangCollege of Preclinical Medicine, Fujian Medical University, Fuzhou, PR China Institutes of Reproductive Sciences, Fujian Medical University, Fuzhou, PR China The Affiliated Fuzhou First Hospital, Fujian Medical University, Fuzhou, PR China Fuzhou Maternity & Child Healthcare Hospital, Fuzhou, PR China hyffjlyxl@163.com yangxiaoyu683@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histone H3 lysine 9 dimethylation (H3K9me2) hypermethylation is thought to be a major influential factor in cellular reprogramming, such as somatic cell nuclear transfer (SCNT) and induction of pluripotent stem cells (iPSCs). The diazepin-quinazolin-amine derivative (BIX-01294) specifically inhibits the activity of histone methyltransferase EHMT2 (euchromatic histone-lysine N-methyltransferase 2) and reduces H3K9me2 levels in cells. The imprinted gene small nuclear ribonucleoprotein N (Snrpn) is of particular interest because of its important biological functions. The objective of the present study was to investigate the effect of BIX-01294 on H3K9me2 levels and changes in Snrpn DNA methylation and histone H3K9me2 in mouse embryonic fibroblasts (MEFs). Results showed that 1.3 μM BIX-01294 markedly reduced global levels of H3K9me2 with almost no cellular toxicity. There was a significant decrease in H3K9me2 in promoter regions of the Snrpn gene after BIX-01294 treatment. A significant increase in methylation of the Snrpn differentially methylated region 1 (DMR1) and slightly decreased transcript levels of Snrpn were found in BIX-01294-treated MEFs. These results suggest that BIX-01294 may reduce global levels of H3K9me2 and affect epigenetic modifications of Snrpn in MEFs.

Indexed as

AnimalsAzepinesCells, CulturedDNA MethylationFibroblastsGene Expression Regulation, DevelopmentalGenomic ImprintingHistone-Lysine N-MethyltransferaseHistonesMiceQuinazolinesRibonucleoproteins, Small NuclearAzepinesBIX 01294G9a protein, mouseHistone-Lysine N-MethyltransferaseHistonesQuinazolinesRibonucleoproteins, Small Nuclearcellular toxicitydiazepin-quinazolin-amine derivative (BIX-01294)DNA methylationhistone dimethylationmouse embryonic fibroblastsSnrpn

Identifiers

PMID26285804
PMCPMC4613706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.